收藏切换
Tetrandrine ameliorates pulmonary fibrosis by inhibiting ROS-mediated fibroblast activation
收藏切换
PDF
Ye-chao YAN, Chun-yi GUO, Jia-ming ZHANG, Yun-xuan LI, Ke LI*
Acta Pharmaceutica Sinica | 2024, 59(8) : 2216 - 2226
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(8): 2216-2226
Tetrandrine ameliorates pulmonary fibrosis by inhibiting ROS-mediated fibroblast activation
Full
Ye-chao YAN, Chun-yi GUO, Jia-ming ZHANG, Yun-xuan LI, Ke LI*
Affiliations
  • Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2024-08-12 doi: 10.16438/j.0513-4870.2024-0313
Outline
收藏切换

Pulmonary fibrosis is a chronic and progressive lung disease that poses a threat to human health. Current treatment options are limited, highlighting the urgent need for more effective therapeutic strategies. Tetrandrine (TET), a bis-benzylisoquinoline alkaloid extracted from Stephania tetrandra, has been known for its anti-inflammatory and anti-fibrotic effects, but its specific mechanisms remain unclear. This study investigated the anti-fibrotic effects of TET in a chronic model of pulmonary fibrosis, aiming to delineate the molecular mechanisms underlying TET-mediated inhibition of fibroblast activation. The results showed that TET significantly alleviated the pathological changes in a murine model of multiple bleomycin-induced pulmonary fibrosis and effectively inhibited TGF-β1-induced fibroblast activation. Mechanistically, TET predominantly inhibited the TGF-β/SMAD signaling pathway and diminished intracellular reactive oxygen species (ROS) levels. Utilizing CRISPR-Cas9 library screening, we identified that angiotensin II type 1 receptor associated protein (AGTRAP) and membrane palmitoylated protein 6 (MPP6) played important roles in TET's suppressive impact of ROS levels, with the knockout of two genes attenuating TET's antifibrotic activity. All animal treatment procedures were approved according to the Committee on the Ethics of Animal Experiments of the Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (IMB-20230406D507). This research not only elucidates the pharmacological mechanism of TET but also provides a novel therapeutic avenue for the treatment of pulmonary fibrosis.

pulmonary fibrosis  /  tetrandrine  /  fibroblast activation  /  reactive oxygen species  /  mitochondria
Ye-chao YAN, Chun-yi GUO, Jia-ming ZHANG, Yun-xuan LI, Ke LI. Tetrandrine ameliorates pulmonary fibrosis by inhibiting ROS-mediated fibroblast activation[J]. Acta Pharmaceutica Sinica, 2024 , 59 (8) : 2216 -2226 . DOI: 10.16438/j.0513-4870.2024-0313
Year 2024 volume 59 Issue 8
PDF
288
136
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0313
  • Receive Date:2024-04-02
  • Online Date:2025-11-26
  • Published:2024-08-12
Article Data
Affiliations
History
  • Received:2024-04-02
  • Revised:2024-05-11
Funding
Affiliations
    Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0313
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT